Matches in Wikidata for { <http://www.wikidata.org/entity/Q98574868> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q98574868 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98574868 description "bài báo khoa học" @default.
- Q98574868 description "im August 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q98574868 description "scientific article published on 01 August 2020" @default.
- Q98574868 description "wetenschappelijk artikel" @default.
- Q98574868 description "наукова стаття, опублікована 1 серпня 2020" @default.
- Q98574868 name "Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study" @default.
- Q98574868 name "Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study" @default.
- Q98574868 type Item @default.
- Q98574868 label "Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study" @default.
- Q98574868 label "Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study" @default.
- Q98574868 prefLabel "Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study" @default.
- Q98574868 prefLabel "Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study" @default.
- Q98574868 P1433 Q98574868-15D3EDF1-0ADA-4B34-AF1F-A697AC2158AA @default.
- Q98574868 P1476 Q98574868-25FB80A5-79B9-4003-AF37-94350D5DF1BB @default.
- Q98574868 P2093 Q98574868-078E79E6-734C-4168-80E8-84E337C5044C @default.
- Q98574868 P2093 Q98574868-0885CD65-1982-47FF-8C2D-0DD6C788723A @default.
- Q98574868 P2093 Q98574868-27E1CA98-9BA2-4ECB-8DCD-CEF0E7475CC8 @default.
- Q98574868 P2093 Q98574868-4325ED49-51EA-4869-8426-0595D51D451C @default.
- Q98574868 P2093 Q98574868-499E8C72-D088-4F9A-855C-74D814023EDB @default.
- Q98574868 P2093 Q98574868-51003B03-F49E-4754-B823-4FAD5DFCC7E5 @default.
- Q98574868 P2093 Q98574868-51B53868-5311-46C5-B8B4-344E32783328 @default.
- Q98574868 P2093 Q98574868-5816A3F4-8243-44CD-B73E-84D312C35C4F @default.
- Q98574868 P2093 Q98574868-6124C9EE-CF94-4248-8FFD-523DCAE7EFA5 @default.
- Q98574868 P2093 Q98574868-7EC04E75-8359-4BFB-8D5E-92B117604B7C @default.
- Q98574868 P2093 Q98574868-AEE01AF3-DCA9-4785-B22C-2476B45EF017 @default.
- Q98574868 P2093 Q98574868-B40C20F0-B653-4968-93F9-2C8A81EA8CB2 @default.
- Q98574868 P2093 Q98574868-F0E93E26-79AF-4C80-A49B-90E91AEC8E1E @default.
- Q98574868 P31 Q98574868-A0AFCBCA-2BDF-4AC4-80E7-B6B3B73825C8 @default.
- Q98574868 P356 Q98574868-B4572DB9-A82A-4DF9-B093-6ED93E871B07 @default.
- Q98574868 P433 Q98574868-1E30F625-0789-43F8-AF18-C894B6234D80 @default.
- Q98574868 P478 Q98574868-BD5D8C2C-D664-4C93-B267-B4549CDA24E8 @default.
- Q98574868 P50 Q98574868-437A376E-A0F2-4DCD-A01A-55591246B8D3 @default.
- Q98574868 P50 Q98574868-A444F34F-CE2B-49A9-A9A2-7562891B2F84 @default.
- Q98574868 P50 Q98574868-C670ACBC-D7BC-40EF-B5C0-6ABBCAFD298E @default.
- Q98574868 P50 Q98574868-F90BBF36-9C9B-46F6-B6F8-FC4FAD03E39D @default.
- Q98574868 P577 Q98574868-4D1C4AFF-F495-49F6-84B0-71E54A7F978A @default.
- Q98574868 P698 Q98574868-9C0F0DE4-8352-4DE6-8A8A-60BF57B5F650 @default.
- Q98574868 P921 Q98574868-9E00CD66-83CE-4639-861A-79287A8AEC77 @default.
- Q98574868 P356 ESMOOPEN-2020-000719 @default.
- Q98574868 P698 32817059 @default.
- Q98574868 P1433 Q53951848 @default.
- Q98574868 P1476 "Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study" @default.
- Q98574868 P2093 "Andrea Fontana" @default.
- Q98574868 P2093 "Antonella Lai" @default.
- Q98574868 P2093 "Arlindo R Ferreira" @default.
- Q98574868 P2093 "Barbara Cardinali" @default.
- Q98574868 P2093 "Claudia Bighin" @default.
- Q98574868 P2093 "Elena Poletto" @default.
- Q98574868 P2093 "Eva Blondeaux" @default.
- Q98574868 P2093 "Federico Sottotetti" @default.
- Q98574868 P2093 "Filippo Montemurro" @default.
- Q98574868 P2093 "Gabriele Minuti" @default.
- Q98574868 P2093 "Piero Fregatti" @default.
- Q98574868 P2093 "Silvia Mura" @default.
- Q98574868 P2093 "Valentina Sini" @default.
- Q98574868 P31 Q13442814 @default.
- Q98574868 P356 "10.1136/ESMOOPEN-2020-000719" @default.
- Q98574868 P433 "4" @default.
- Q98574868 P478 "5" @default.
- Q98574868 P50 Q38546525 @default.
- Q98574868 P50 Q38546536 @default.
- Q98574868 P50 Q39600020 @default.
- Q98574868 P50 Q92485091 @default.
- Q98574868 P577 "2020-08-01T00:00:00Z" @default.
- Q98574868 P698 "32817059" @default.
- Q98574868 P921 Q412616 @default.